Development of Bet v 1-specific DNA aptamers for quality control of birch pollen extracts

被引：0
|
作者：
Bethanis, A. [1 ]
Ferreira, F. [1 ]
Aglas, L. [1 ]
机构：
[1] Univ Salzburg, Dept Biosci, Salzburg, Austria
来源：
ALLERGY | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0133
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [31] Subcutaneous Immunotherapy with Mannan-conjugated Birch Pollen Allergoids significantly increases bet v1-specific Immunoglobulins in Birch Pollen Allergy Sufferers
    Decker, L.
    Xenofontos, E.
    Raskopf, E.
    Wahrhusen, N.
    England, L.
    Katzke, N.
    Acikel, C.
    Casanovas, M.
    Subiza, J. L.
    Cuevas, M.
    Allekotte, S.
    Moesges, R.
    ALLERGOLOGIE, 2023, 46 (08) : 519 - 519
  • [32] The major birch pollen allergen, Bet v 1, shows ribonuclease activity
    Bufe, A
    Spangfort, MD
    Kahlert, H
    Schlaak, M
    Becker, WM
    PLANTA, 1996, 199 (03) : 413 - 415
  • [33] Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen
    Hartl, A
    Kiesslich, J
    Weiss, R
    Bernhaupt, A
    Mostböck, S
    Scheiblhofer, S
    Edner, C
    Ferreira, F
    Thalhamer, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : 107 - 113
  • [34] Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
    Mahler, V
    Vrtala, S
    Kuss, O
    Diepgen, TL
    Suck, R
    Cromwell, O
    Fiebig, H
    Hartl, A
    Thalhamer, J
    Schuler, G
    Kraft, D
    Valenta, R
    CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (01): : 115 - 122
  • [35] Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy
    Linhart, B.
    Narayanan, M.
    Focke-Tejkl, M.
    Wrba, F.
    Vrtala, S.
    Valenta, R.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2014, 44 (02): : 278 - 287
  • [36] Bet v 1-specific IgE levels and PR-10 reactivity discriminate silent sensitization from phenotypes of birch allergy
    Elisyutina, Olga
    Fedenko, Elena
    Campana, Raffaela
    Litovkina, Alla
    Ilina, Nataliya
    Kudlay, Dmitry
    Egorenkov, Evgenii
    Smirnov, Valeriy
    Valenta, Rudolf
    Lupinek, Christian
    Khaitov, Musa
    ALLERGY, 2019, 74 (12) : 2525 - 2529
  • [37] Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE
    Reginald, Kavita
    Eckl-Dorna, Julia
    Zafred, Domen
    Focke-Tejkl, Margarete
    Lupinek, Christian
    Niederberger, Verena
    Keller, Walter
    Valenta, Rudolf
    IMMUNOLOGY AND CELL BIOLOGY, 2013, 91 (02): : 167 - 172
  • [38] Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients
    Nony, E.
    Bouley, J.
    Le Mignon, M.
    Lemoine, P.
    Jain, K.
    Horiot, S.
    Mascarell, L.
    Pallardy, M.
    Vincentelli, R.
    Leone, P.
    Roussel, A.
    Batard, T.
    Abiteboul, K.
    Robin, B.
    de Beaumont, O.
    Arvidsson, M.
    Rak, S.
    Moingeon, P.
    ALLERGY, 2015, 70 (07) : 795 - 804
  • [39] Development of a sensitive and stable chemiluminescent immunoassay for detection of birch pollen allergic specific IgE based on recombinant Bet v1 protein
    Gao, Jinyan
    Cai, Rongfeng
    Zhou, Nandi
    JOURNAL OF IMMUNOLOGICAL METHODS, 2021, 493
  • [40] Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients
    Nony, E.
    Le Mignon, M.
    Lemoine, P.
    Jain, K.
    Abiteboul, K.
    Arvidsson, M.
    Rak, S.
    Moingeon, P.
    ALLERGY, 2016, 71 : 61 - 61
12345